BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/15/2015 11:01:00 AM | Browse: 1860 | Download: 2327
Publication Name World Journal of Gastroenterology
Manuscript ID 12330
Country Taiwan
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Pharmacology & Pharmacy
Manuscript Type Basic Study
Article Title Increase in apoptosis by combination of metformin with silibinin in human colorectal cancer cells
Manuscript Source Invited Manuscript
All Author List Cheng-Chia Tsai, Tang-Wei Chuang, Li-Jen Chen, Ho-Shan Niu, Kun-Ming Chung, Juei-Tang Cheng and Kao-Chang Lin
Funding Agency and Grant Number
Funding Agency Grant Number
Chi Mei Medical Center in Taiwan CMFHR10302(partly)
Corresponding Author Juei-Tang Cheng, PhD, FCP, Professor, Institute of Medical Sciences, Chang Jung Christian University, Geuiren, Tainan City 71101, Taiwan. jtcheng@mail.cjcu.edu.tw
Key Words Silibinin; Metformin; COLO 205; Mammol/Lalian target of rapamycin; Apoptosis; Colorectal cancer
Core Tip Silibinin is known to provide protection against hepatotoxic stress. Silibinin has also been shown to have high efficacy against cancer cells through increased expression of the phosphatase and tensin homolog; Metformin, a well-known antidiabetic agent, has recently been reported to inhibit cancer by increasing adenosine monophosphate-activated protein kinase expression. We investigated the effect of metformin on silibinin-induced apoptosis in human colorectal cancer cells. The combined treatment of human colorectal cancer cells with silibinin and metformin may induce apoptosis at a dose that does not affect human colonic epithelial cells. This finding reveals a potential therapeutic strategy for the treatment of colorectal cancer.
Publish Date 2015-04-15 11:01
Citation Tsai CC, Chuang TW, Chen LJ, Niu HS, Chung KM, Cheng JT, Lin KC. Increase in apoptosis by combination of metformin with silibinin in human colorectal cancer cells. World J Gastroenterol 2015; 21(14): 4169-4177
URL http://www.wjgnet.com/1007-9327/full/v21/i14/4169.htm
DOI http://dx.doi.org/10.3748/wjg.v21.i14.4169
Full Article (PDF) WJG-21-4169.pdf
Full Article (Word) WJG-21-4169.doc